Pesticide Transparency and Environmental Protections

Summary#

This is a proposed change to the Pest Control Products Regulations published by Health Canada on June 15, 2024. It would make it easier for Canadian researchers to see some previously confidential pesticide test data, set clearer rules for applications that ask for maximum residue limits on imported foods, and give regulators explicit authority to get information on cumulative environmental effects and on species at risk. The proposal is open for comment for 70 days (it is not law yet).

What it does#

• Confidential test data (CTD)

  • Lets Canadian residents request access to CTD for “research” or “reanalysis” without the old affidavit step.
  • Requesters must prove identity and Canadian residency, say how long they need the data (up to 5 years), and explain the research purpose.
  • Data would be made available only after a final registration decision, or at the proposed-decision stage for post‑market reviews.
  • Requesters must store and access the data in Canada, cannot publish or use it to register a product, and must destroy copies when access ends. Registrants are notified when their CTD is released.
  • Misuse can lead to enforcement action. The CTD rules would come into force 180 days after these regulations are published in Canada Gazette, Part II.

• Maximum residue limits (MRLs)

  • Codifies what information an applicant must give when asking the government to set or change an MRL for an imported food or for a use not registered in Canada.
  • Includes things like the foreign label, rationale, and studies used to support the MRL.
  • A public notification step for these MRL applications was already put in place in spring 2024.

• Cumulative effects on the environment (CEE)

  • Gives the Minister explicit authority to require information about cumulative environmental effects for pesticides that share a common mechanism of toxicity.
  • That information would be considered in environmental risk assessments once relevant scientific methods are available.

• Species at risk (SAR)

  • Gives the Minister explicit authority to require information about effects on species at risk (as defined in the Species at Risk Act).
  • The proposal does not require new testing on species at risk; it just clarifies the regulator’s power to request relevant information.

• Timing and costs (summary)

  • Health Canada says most costs would be small. The agency estimates about 593 applications/evaluations per year and that roughly 80% of registrants are small businesses.
  • Administrative burden from the CTD change was estimated at about $39,521 (annualized, per the one‑for‑one rule). Health Canada previously announced a $42 million investment in the PMRA over three years (background).

Who's affected#

• Registrants and applicants who submit pesticide data (manufacturers, importers, registrants).
• Researchers, academics, and non‑governmental organizations that want to study or reanalyse pesticide test results.
• Small businesses that register pesticides (Health Canada estimates about 80% of registrants are small businesses).
• Food importers and those who submit MRL applications for imported foods.
• Federal partners such as Environment and Climate Change Canada (ECCC) and provincial/territorial regulators who work on environmental assessments.
• Members of the public who follow pesticide decisions or want more transparency.

If anything above is unclear in the proposal (for example exactly how the CTD will be delivered in practice), Health Canada says it will publish guidance during the consultation period.

Why it matters#

• Transparency and independent science: allowing qualified Canadian researchers to inspect CTD can let outside scientists verify or reanalyse the data behind pesticide decisions. That can increase public confidence.
• Faster, clearer MRL handling: clearer application rules and public notices help importers, traders, and consumers understand when new residue limits are under review.
• Stronger environmental focus: giving regulators explicit authority to ask for information on cumulative effects and species at risk makes it more likely those issues are considered formally during reviews.
• Limited trade‑offs: access is restricted (only residents, no publishing, storage in Canada), so researchers gain access but commercial protections remain. Health Canada says the costs are small, but registrants will have some extra paperwork to identify which data are confidential.
• This is a proposal: the rules would only take effect after the Canada Gazette, Part II step and the set timelines. Comments on the proposal are being invited for 70 days from the publication date.